BAM
CNTA

Bellevue Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Bellevue Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-70
Closed -$1.01K – 474
2025
Q1 		$1.01K Buy
+70
New +$1.01K ﹤0.01% 477